Aprea Therapeutics, Inc. - Common Stock

Share · US03836J2015 · APRE (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

29.10.2025 23:26

Current Prices from Aprea Therapeutics, Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	APRE	USD	29.10.2025 23:26	1,44 USD	0,02 USD +1,41 %

Share Float & Liquidity

Free Float 79,58 %

Shares Float 4,64 M

Shares Outstanding 5,83 M

Company Profile for Aprea Therapeutics, Inc. - Common Stock Share

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.

Get up to date insights from finAgent about Aprea Therapeutics, Inc. - Common Stock

Company Data

Name Aprea Therapeutics, Inc. - Common Stock

Company Aprea Therapeutics, Inc.

Symbol APRE

Website https://atrinpharma.com

Primary Exchange

NASDAQ

ISIN US03836J2015

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Oren Gilad

Country United States of America

Currency USD

Employees 0,0 T

Address 535 Boylston St., 02116 Boston

IPO Date 2019-10-03

Ticker Symbols

Name	Symbol
NASDAQ	APRE

More Shares

Investors who hold Aprea Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:

CPPIB CAP. 17/27 MTN REGS Bond

VEDES ANLEIHE 17/22 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog